From Fragmented Estimates to a Defensible, 100% Complete Inventory
You’ve seen how Bayer and Carbon Minds are closing the data gaps that standard databases can’t reach. Now, let’s apply that same systematic approach to your specific procurement list.
Stop waiting for perfect supplier data.
In the pharmaceutical industry, specialized substances and small-volume chemicals often mean “No Data Found.” Traditional spend-based proxies are too generic for internal audits and fail to identify real emission reduction levers.
We help you move beyond "No Data" by triangulating:
Direct Database Coverage
Immediate mapping of your substances to 130,000+ region- and technology-specific datasets.
Retrosynthesis Modeling
Building defensible emission profiles for specialized substances based on chemical synthesis pathways.
Advanced Proxy Selection
Using molecular similarity to fill remaining gaps with high-confidence, domain-specific data.
Get Your Pharmaceutical Data Gap Report
Book a 30-minute strategy session to transition from a patchy inventory to a decision-grade Scope 3.1 baseline.
In this call, we will:
Review your substance list
Walk through our secure Excel template for CAS-number submission.
Identify immediate wins
See which of your purchased substances can be mapped instantly to our database.
Strategize for specialty gaps
Determine where retrosynthesis modeling or advanced proxies are required to reach 100% completeness.
Define your path to audit-readiness
Ensure your PCF and LCA results meet the rigor required for CSRD, SEC, and supplier engagement.
Good data is essential for assessments, to facilitate discussions with suppliers, and to capture the impact of reductions.
— Jens Plambeck, Senior Manager Supplier Decarbonization at Bayer
- All modeling follows ISO 14040/44 and 14067 standards.
- Built for the complexity of specialized chemical value chains.
- Your procurement data is handled with industry-standard security protocols.